New case of t(3;17)(q26;q22) as an additional change in a Philadelphia-positive chronic myelogenous leukemia in acceleration-Reference-Cited by-同舟云学术

New case of t(3;17)(q26;q22) as an additional change in a Philadelphia-positive chronic myelogenous leukemia in acceleration

Published:1992-05 Issue:1 Volume:60 Page:90-92
ISSN:0165-4608
Container-title:Cancer Genetics and Cytogenetics
language:en
Short-container-title:Cancer Genetics and Cytogenetics

Author:

Mugneret Francine,Solary Eric,Favre Bernardine,Caillot Denis,Sidaner Isabelle,Guy Henri

Publisher

Elsevier BV

Subject

Cancer Research,Genetics,Molecular Biology

Reference12 articles.

1. Translocation t(3;17)(q26;q22): A marker of acute disease in myeloproliferative disorders?;Mecucci;Cancer Genet Cytogenet,1984

2. Structural chromosome changes in acute nonlymphocytic leukemia;Sandberg,1990

3. Ph1-positive CML associated with megakaryocytic hyperplasia and thrombocytemia and an abnormality of chromosome number 3;Carbonell;Cancer Genet Cytogenet,1982

4. Translocation (3;21) in Philadelphia positive chronic myeloid leukemia: High resolution chromosomal analysis and immunological study on five new cases;Lafage-Pochitaloff-Huvalé;Leukemia,1989

5. Cytogenetics findings in adult acute leukemia and myeloproliferative disorders with an involvement of megakaryocyte lineage;Ohyashiki;Cancer,1990

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. EVI1 overexpression in t(3;17) positive myeloid malignancies results from juxtaposition of EVI1 to the MSI2 locus at 17q22;Haematologica;2008-09-24

2. EVI1 and hematopoietic disorders: History and perspectives;Gene;2006-03

3. “Acute myelogenous leukemia like” translocations in CML blast crisis: Two new cases of inv(16)/t(16;16) and a review of the literature;Leukemia Research;2006-02

4. EVI1is consistently expressed as principal transcript in common and rare recurrent 3q26 rearrangements;Genes, Chromosomes and Cancer;2005-12-08

5. The EVI-1 gene — its role in pathogenesis of human leukemias;Leukemia Research;2000-07